𝔖 Bobbio Scriptorium
✦   LIBER   ✦

An Overview of the Preclinical Aspects of Topiramate: Pharmacology, Pharmacokinetics, and Mechanism of Action

✍ Scribed by Richard P. Shank; Joseph F. Gardocki; Anthony J. Streeter; Bruce E. Maryanoff

Book ID
109108309
Publisher
Wiley (Blackwell Publishing)
Year
2000
Tongue
English
Weight
756 KB
Volume
41
Category
Article
ISSN
0013-9580

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Pinacidil monohydrateβ€”a novel vasodilato
Pinacidil monohydrateβ€”a novel vasodilator: Review of preclinical pharmacology and mechanism of action
✍ Marlene L. Cohen πŸ“‚ Article πŸ“… 1986 πŸ› John Wiley and Sons 🌐 English βš– 639 KB

Pinacidil dose-dependently decreased blood pressure in normotensive, renal hypertensive, spontaneously hypertensive, and neurogenic hypertensive rats; in anesthetized cats; and in normotensive and renal hypertensive dogs by a mechanism associated with decreased total peripheral resistance and reflex

Lesch-Nyhan syndrome: An overview of pha
Lesch-Nyhan syndrome: An overview of pharmacologic and molecular genetic aspects
✍ Johnson, Lynelle T. ;Patel, Pragna I. πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 1019 KB

The enzyme hypoxanthine phosphoribosyltransferase (HPRT), expressed at low levels in non-neuronal tissues and higher levels in the brain, catalyzes the cellular salvage of the purine bases hypoxanthine and guanine. A complete deficiency of HPRT results in Lesch-Nyhan syndrome (LNS). LNS is character

An overview of the pharmacology and phar
An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane
✍ Aman U. Buzdar; John F. R. Robertson; Wolfgang Eiermann; Jean-Marc Nabholtz πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 123 KB

## Background: The newer generation, nonsteroidal aromatase inhibitors (ais) anastrozole and letrozole have shown superior efficacy compared with tamoxifen as first-line treatments and compared with megestrol acetate as second-line therapy in postmenopausal women with advanced breast carcinoma. in